HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$13.99−0.41 (-2.85%)
Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –
HUTCHMED (China) revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
HUTCHMED (China)'s revenue for the twelve months ending Dec 31, 2019 was $204.89M, down 4.3% year over year. For fiscal 2025 it was $548.51M, down 13.0% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $838.00M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $548.51M | -13.0% |
| FY2024 | Dec 31, 2024 | $630.20M | -24.8% |
| FY2023 | Dec 31, 2023 | $838.00M | +96.5% |
| FY2022 | Dec 31, 2022 | $426.41M | +19.7% |
| FY2021 | Dec 31, 2021 | $356.13M | +56.2% |
| FY2020 | Dec 31, 2020 | $227.98M | +11.3% |
| FY2019 | Dec 31, 2019 | $204.89M | -4.3% |
| FY2018 | Dec 31, 2018 | $214.11M | -11.2% |
| FY2017 | Dec 31, 2017 | $241.20M | +11.6% |
| FY2016 | Dec 31, 2016 | $216.08M | +21.3% |
| FY2015 | Dec 31, 2015 | $178.20M | +104.1% |
| FY2014 | Dec 31, 2014 | $87.33M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $53.34M | +0.4% |
| Q3 FY2019 | Sep 30, 2019 | $49.35M | -16.1% |
| Q2 FY2019 | Jun 30, 2019 | $50.03M | +0.4% |
| Q1 FY2019 | Mar 31, 2019 | $52.17M | -0.3% |
| Q4 FY2018 | Dec 31, 2018 | $53.11M | – |
| Q3 FY2018 | Sep 30, 2018 | $58.81M | – |
| Q2 FY2018 | Jun 30, 2018 | $49.85M | – |
| Q1 FY2018 | Mar 31, 2018 | $52.34M | – |
See a number that looks wrong?